Back to Journals » Drug Design, Development and Therapy » Volume 13

Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib

Total article views   HTML views PDF downloads Totals
7,088 Dovepress* 6,744+ 1,034 7,778
PubMed Central* 344 109 453
Totals 7,088 1,143 8,231
*Since 12 December 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar